| Comprehensive Organic Synthesis P Wipf Trost, BM, Fleming, I., Eds 5, 827, 1991 | 1468* | 1991 |
| Nanoparticles in cellular drug delivery AH Faraji, P Wipf Bioorganic & medicinal chemistry 17 (8), 2950-2962, 2009 | 1281 | 2009 |
| Synthetic studies of biologically active marine cyclopeptides P Wipf Chemical Reviews 95 (6), 2115-2134, 1995 | 729 | 1995 |
| Targeting mitochondria AT Hoye, JE Davoren, P Wipf, MP Fink, VE Kagan Accounts of chemical research 41 (1), 87-97, 2008 | 721 | 2008 |
| Fluorous synthesis: A fluorous-phase strategy for improving separation efficiency in organic synthesis A Studer, S Hadida, R Ferritto, SY Kim, P Jeger, P Wipf, DP Curran Science 275 (5301), 823-826, 1997 | 709 | 1997 |
| Synthesis of functionalized oxazolines and oxazoles with DAST and Deoxo-Fluor AJ Phillips, Y Uto, P Wipf, MJ Reno, DR Williams Organic letters 2 (8), 1165-1168, 2000 | 595 | 2000 |
| Cytochrome c/cardiolipin relations in mitochondria: a kiss of death VE Kagan, HA Bayır, NA Belikova, O Kapralov, YY Tyurina, VA Tyurin, ... Free Radical Biology and Medicine 46 (11), 1439-1453, 2009 | 513 | 2009 |
| Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3-kinase signaling NT Ihle, R Williams, S Chow, W Chew, MI Berggren, G Paine-Murrieta, ... Molecular cancer therapeutics 3 (7), 763-772, 2004 | 430 | 2004 |
| A solid phase protocol of the Biginelli dihydropyrimidine synthesis suitable for combinatorial chemistry P Wipf, A Cunningham Tetrahedron Letters 36 (43), 7819-7822, 1995 | 400 | 1995 |
| 2.3 Å resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition S Banerjee, A Bartesaghi, A Merk, P Rao, SL Bulfer, Y Yan, N Green, ... Science 351 (6275), 871-875, 2016 | 372 | 2016 |
| Stereochemical control in the ester enolate Claisen rearrangement. 1. Stereoselectivity in silyl ketene acetal formation RE Ireland, P Wipf, JD Armstrong III The Journal of Organic Chemistry 56 (2), 650-657, 1991 | 372 | 1991 |
| Synthetic applications of organochlorozirconocene complexes P Wipf, H Jahn Tetrahedron 52 (40), 12853-12910, 1996 | 370 | 1996 |
| A new synthesis of highly functionalized oxazoles P Wipf, CP Miller The Journal of Organic Chemistry 58 (14), 3604-3606, 1993 | 366 | 1993 |
| A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach TL Nguyen, C McGrath, AR Hermone, JC Burnett, DW Zaharevitz, BW Day, ... Journal of medicinal chemistry 48 (19), 6107-6116, 2005 | 360 | 2005 |
| Fluorous synthesis: Fluorous protocols for the Ugi and Biginelli multicomponent condensations A Studer, P Jeger, P Wipf, DP Curran The Journal of organic chemistry 62 (9), 2917-2924, 1997 | 351 | 1997 |
| Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance NT Ihle, R Lemos Jr, P Wipf, A Yacoub, C Mitchell, D Siwak, GB Mills, ... Cancer research 69 (1), 143-150, 2009 | 317 | 2009 |
| Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury J Ji, AE Kline, A Amoscato, AK Samhan-Arias, LJ Sparvero, VA Tyurin, ... Nature neuroscience 15 (10), 1407-1413, 2012 | 293 | 2012 |
| Stochastic voyages into uncharted chemical space produce a representative library of all possible drug-like compounds AM Virshup, J Contreras-García, P Wipf, W Yang, DN Beratan Journal of the American Chemical Society 135 (19), 7296-7303, 2013 | 289 | 2013 |
| Formal total synthesis of (+)-diepoxin σ P Wipf, JK Jung The Journal of organic chemistry 65 (20), 6319-6337, 2000 | 265 | 2000 |
| Small molecule modulators of endogenous and co-chaperone-stimulated Hsp70 ATPase activity SW Fewell, CM Smith, MA Lyon, TP Dumitrescu, P Wipf, BW Day, ... Journal of Biological Chemistry 279 (49), 51131-51140, 2004 | 251 | 2004 |
Valerian KaganProfessor, University of Pittsburgh在 pitt.edu 的电子邮件经过验证
